From Adweek · Andrea Michelson · · 1m 10s
Noom Ad Highlights GLP-1 Weight Rebound Fears
Noom's dystopian ad warns GLP-1 users about weight rebound risks after stopping medication.
In brief
Noom's dystopian ad warns GLP-1 users about weight rebound risks after stopping medication. Noom's ad shows weight regain fears for GLP-1 users who stop medication, emphasizing habit support to prevent rebound. Originally reported by Adweek.
Noom's New Ad Concept
Noom's latest ad features Rebel Wilson in a dystopian scenario where smart home devices warn of weight regain after losing weight.
“Weight regain doesn't care”
Smart Home Paranoia Concept
The ad uses smart home devices like TV, speaker, smoke alarm, and Roomba to deliver the warning that weight regain doesn't care.
“Weight regain doesn't care”
GLP-1 Medication Usage
Eleven in twelve people taking GLP-1 drugs will pause or stop completely at some point despite doctors' advice.
“Eleven in twelve”
Habit Support for GLP-1 Users
Noom's habit formation approach helps users maintain weight loss after stopping GLP-1 medication through tailored support.
“tailored support”
Research on Weight Rebound
Noom research shows members who continued habits after stopping GLP-1 kept off more weight than non-Noom users who discontinued medication.
“kept off more weight”
GLP-1 Usage Challenges
Side effects, financial issues, or life changes often cause people to stop GLP-1 medication despite doctors' recommendations.
“side effects”
In short
Noom's ad shows weight regain fears for GLP-1 users who stop medication, emphasizing habit support to prevent rebound.
